The mechanism of the Sr2+ anti-osteoporosis action appears to be different from those mentioned above: it does not fully substitute for the native Ca2+ in CaSR but rather binds and activates the receptor as it closely mimics the basic physico-chemical and structural features of the native agonist. This evidence concerns the gene CASR and osteoporosis.